Regulation of p27Kip1 by mitogen-induced tyrosine phosphorylation

Extracellular mitogen signal transduction is initiated by ligand binding to specific receptors of target cells. This causes a cellular response that frequently triggers the activation of tyrosine kinases. Non-receptor kinases like Src and Lyn can directly phosphorylate the Cdk inhibitor protein p27Kip1. Tyrosine phosphorylation can cause impaired Cdk-inhibitory activity and decreased stability of p27. In addition to these non-receptor tyrosine kinases, the receptor-associated tyrosine kinase Janus kinase 2 (JAK2) was recently identified to phosphorylate p27. JAK2 becomes activated through binding of various cytokines and growth factors to their corresponding receptors and can directly bind and selectively phosphorylate tyrosine residue 88 (Y88) of the Cdk inhibitor p27. This impairs Cdk inhibition by p27 and promotes its ubiquitin-dependent proteasomal degradation. Via this mechanism, JAK2 can link cytokine and growth factor initiated signal transduction to p27 regulation, whereas oncogenes like JAK2V617F or BCR-Abl can use this mechanism to inactivate the Cdk inhibitor.

[1]  Jung Weon Lee,et al.  JNK signaling activity regulates cell-cell adhesions via TM4SF5-mediated p27(Kip1) phosphorylation. , 2012, Cancer letters.

[2]  L. Hengst,et al.  Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control , 2011, Oncogene.

[3]  D. Bowtell,et al.  Siah1/SIP regulates p27kip1 stability and cell migration under metabolic stress , 2011, Cell cycle.

[4]  Zhenlin Ju,et al.  Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo , 2011, Breast Cancer Research and Treatment.

[5]  D. Bashford,et al.  Incomplete Folding upon Binding Mediates Cdk4/Cyclin D Complex Activation by Tyrosine Phosphorylation of Inhibitor p27 Protein* , 2011, The Journal of Biological Chemistry.

[6]  Karl A. Merrick,et al.  Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation. , 2011, Molecular cell.

[7]  R. Kriwacki,et al.  The role of the LH subdomain in the function of the Cip/Kip cyclin-dependent kinase regulators. , 2011, Biophysical journal.

[8]  A. Deblasio,et al.  JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. , 2011, Cancer cell.

[9]  K. Fukunaga,et al.  CaMKII phosphorylates serine 10 of p27 and confers apoptosis resistance to HeLa cells. , 2010, Biochemical and biophysical research communications.

[10]  Andrew J. Bannister,et al.  LIF independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease , 2010, Nature Cell Biology.

[11]  P. Boya,et al.  Tumor suppressor p27Kip1 undergoes endolysosomal degradation through its interaction with sorting nexin 6 , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  T. Hunter,et al.  Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors , 2010, Cell cycle.

[13]  N. Nozaki,et al.  Interaction of human MCM2-7 proteins with TIM, TIPIN and Rb. , 2010, Journal of biochemistry.

[14]  K. Coulonval,et al.  Rb inactivation in cell cycle and cancer: The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase , 2010, Cell cycle.

[15]  Riaan Conradie,et al.  Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex , 2010, The FEBS journal.

[16]  J. Slingerland,et al.  p27 as Jekyll and Hyde: Regulation of cell cycle and cell motility , 2009, Cell cycle.

[17]  Andrew J. Bannister,et al.  JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin , 2009, Nature.

[18]  T. Naoe,et al.  p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation. , 2009, Biochemical and biophysical research communications.

[19]  D. Helfman,et al.  RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility , 2009, Proceedings of the National Academy of Sciences.

[20]  S. Paternot,et al.  Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation , 2009, Molecular and Cellular Biology.

[21]  M. Barbacid,et al.  Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.

[22]  W. J. Pledger,et al.  Inhibition of p27Kip1 gene transcription by mitogens , 2009, Cell cycle.

[23]  R. P. Fisher,et al.  p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes , 2008, Molecular and Cellular Biology.

[24]  R. Assoian,et al.  Transcriptional regulation of the cyclin D1 gene at a glance , 2008, Journal of Cell Science.

[25]  W. Vainchenker,et al.  Miscreant myeloproliferative disorder stem cells , 2008, Leukemia.

[26]  Shunichi Takeda,et al.  Cyclin-dependent kinases and cell-cycle transitions: does one fit all? , 2008, Nature Reviews Molecular Cell Biology.

[27]  K. Nakayama,et al.  Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease. , 2008, Blood.

[28]  J. Slingerland,et al.  Phosphorylation of p27Kip1 Regulates Assembly and Activation of Cyclin D1-Cdk4 , 2008, Molecular and Cellular Biology.

[29]  T. Tsuruo,et al.  Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. , 2008, Cancer research.

[30]  M. Pagano,et al.  Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer , 2008, Nature Reviews Cancer.

[31]  M. Tomasson,et al.  The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes. , 2008, Blood.

[32]  Ludger Hengst,et al.  The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy , 2008, Nature Reviews Cancer.

[33]  S. Blain Switching cyclin D-Cdk4 kinase activity on and off , 2008, Cell cycle.

[34]  James M. Roberts,et al.  CDK inhibitors: cell cycle regulators and beyond. , 2008, Developmental cell.

[35]  S. Rane,et al.  Hematopoietic cytokine receptor signaling , 2007, Oncogene.

[36]  S. Blain,et al.  Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity , 2007, Molecular and Cellular Biology.

[37]  D. Gary Gilliland,et al.  Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders , 2007, Nature Reviews Cancer.

[38]  James M. Roberts,et al.  A Skp2 autoinduction loop and restriction point control , 2007, The Journal of cell biology.

[39]  Gordon B. Mills,et al.  The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis , 2007, Nature Cell Biology.

[40]  L. Hengst,et al.  p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 , 2007, Cell.

[41]  Richard W. Kriwacki,et al.  Cdk-Inhibitory Activity and Stability of p27 Kip1 Are Directly Regulated by Oncogenic Tyrosine Kinases , 2007, Cell.

[42]  M. Manns,et al.  C‐terminal phosphorylation controls the stability and function of p27kip1 , 2006, The EMBO journal.

[43]  Yang Guo,et al.  p27Kip1 and Cyclin Dependent Kinase 2 Regulate Passage Through the Restriction Point , 2006, Cell cycle.

[44]  G. Bjursell,et al.  Nuclear Jak2 and Transcription Factor NF1-C2: a Novel Mechanism of Prolactin Signaling in Mammary Epithelial Cells , 2006, Molecular and Cellular Biology.

[45]  L. Hengst,et al.  Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression. , 2006, Cancer research.

[46]  K. Welte,et al.  Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4. , 2006, Blood.

[47]  E. Musgrove Cyclins: Roles in mitogenic signaling and oncogenic transformation , 2006, Growth factors.

[48]  H. Lodish,et al.  Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  E. Nabel,et al.  The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication , 2005, FEBS letters.

[50]  J. Diehl,et al.  Location, location, location: The role of cyclin D1 nuclear localization in cancer , 2005, Journal of cellular biochemistry.

[51]  G. Viglietto,et al.  Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. , 2005, Carcinogenesis.

[52]  Mario Cazzola,et al.  A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.

[53]  Stefan N. Constantinescu,et al.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.

[54]  Sandra A. Moore,et al.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.

[55]  P. Campbell,et al.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.

[56]  Xin Lu,et al.  Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo. , 2005, Blood.

[57]  Y. Kotake,et al.  Role of Serine 10 Phosphorylation in p27 Stabilization Revealed by Analysis of p27 Knock-in Mice Harboring a Serine 10 Mutation* , 2005, Journal of Biological Chemistry.

[58]  P. Heinrich,et al.  Janus Kinase (Jak) Subcellular Localization Revisited , 2004, Journal of Biological Chemistry.

[59]  L. Hengst,et al.  p27 binds cyclin–CDK complexes through a sequential mechanism involving binding-induced protein folding , 2004, Nature Structural &Molecular Biology.

[60]  E. Friedman,et al.  The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase* , 2004, Journal of Biological Chemistry.

[61]  J. Dumont,et al.  The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. , 2003, Experimental cell research.

[62]  K. Nakayama,et al.  Estrogens Down-regulate p27Kip1 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway* , 2003, Journal of Biological Chemistry.

[63]  M. Pagano,et al.  Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions , 2003, Molecular and Cellular Biology.

[64]  Takashi Tsuruo,et al.  Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization* , 2002, The Journal of Biological Chemistry.

[65]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[66]  E. Nabel,et al.  A growth factor‐dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression , 2002, The EMBO journal.

[67]  J. Slingerland,et al.  Altered p27Kip1 Phosphorylation, Localization, and Function in Human Epithelial Cells Resistant to Transforming Growth Factor β-Mediated G1 Arrest , 2002, Molecular and Cellular Biology.

[68]  Mikhail V. Blagosklonny,et al.  The Restriction Point of the Cell Cycle , 2002, Cell cycle.

[69]  L. Di Marcotullio,et al.  p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis , 2001, The EMBO journal.

[70]  M. Kitagawa,et al.  Phosphorylation at Serine 10, a Major Phosphorylation Site of p27 Kip1 , Increases Its Protein Stability* , 2000, The Journal of Biological Chemistry.

[71]  H. Baumann,et al.  Oncostatin M and Interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells , 2000, Oncogene.

[72]  K. Hirano,et al.  Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor. , 2000, Biochemical and biophysical research communications.

[73]  J. Harbour,et al.  Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.

[74]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[75]  N. Pavletich Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. , 1999, Journal of molecular biology.

[76]  B. Schulman,et al.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[77]  J. Marine,et al.  Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.

[78]  D. Waxman,et al.  Interaction of Growth Hormone-activated STATs with SH2-containing Phosphotyrosine Phosphatase SHP-1 and Nuclear JAK2 Tyrosine Kinase* , 1997, The Journal of Biological Chemistry.

[79]  J. Massagué,et al.  The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. , 1997, Genes & development.

[80]  O. Silvennoinen,et al.  Constitutive nuclear localization of Janus kinases 1 and 2. , 1996, Endocrinology.

[81]  Philip D. Jeffrey,et al.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.

[82]  L. Hengst,et al.  Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.

[83]  R. Sorenson,et al.  Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. , 1995, Endocrinology.

[84]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[85]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[86]  C. Sherr,et al.  Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase , 1994, Molecular and cellular biology.

[87]  A. Pardee,et al.  A restriction point for control of normal animal cell proliferation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[88]  E. P. Kay,et al.  Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells. , 2008, Investigative ophthalmology & visual science.

[89]  James M. Roberts,et al.  A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. , 2006, Genes & development.

[90]  M. Hoshino,et al.  Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration , 2006, Nature Cell Biology.

[91]  L. Hengst,et al.  CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. , 2003, Molecular biology of the cell.

[92]  J. Slingerland,et al.  Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest. , 2002, Molecular and cellular biology.

[93]  Heinz Höfler,et al.  Open Access Research Characterization of a Naturally-occurring P27 Mutation Predisposing to Multiple Endocrine Tumors , 2022 .